APA (7th ed.) Citation

D, A., R, C., J, R., & J, K. (2026). Continuous versus intermittent tacrolimus for graft-versus-host disease prophylaxis in pediatric hematopoietic stem cell transplantation patients (Tic Tac). Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 32(4), 682. https://doi.org/10.1177/10781552241312925

Chicago Style (17th ed.) Citation

D, Asleson, Carr R, Rozmus J, and Kendrick J. "Continuous Versus Intermittent Tacrolimus for Graft-versus-host Disease Prophylaxis in Pediatric Hematopoietic Stem Cell Transplantation Patients (Tic Tac)." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 32, no. 4 (2026): 682. https://doi.org/10.1177/10781552241312925.

MLA (9th ed.) Citation

D, Asleson, et al. "Continuous Versus Intermittent Tacrolimus for Graft-versus-host Disease Prophylaxis in Pediatric Hematopoietic Stem Cell Transplantation Patients (Tic Tac)." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 32, no. 4, 2026, p. 682, https://doi.org/10.1177/10781552241312925.